Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

Amira Marouf; Sammara Chaubard; Raphaël Liévin; Jean Marie Michot; Nicolas Molinari; Julien Rossignol; Doriane Cavalieri; Camille Golfier; Olivier Allangba; Laure Philippe; Benoît Tessoulin; Adrien Chauchet; Bénédicte Deau; Lucie Oberic; Jacques Vargaftig; Aline Moignet; Aline Clavert; Rémy Dulery; Gabriel Brisou; Stéphanie Tardy; Virginie Fataccioli; Roch Houot; René O. Casasnovas; Catherine Thieblemont; Hervé Ghesquières; Sylvain Carras; Steven Le Gouill; Guillaume Cartron; Vincent Ribrag; Morgane Cheminant; Ambroise Marçais; Felipe Suarez; Aurélien Marabelle; Olivier Tournilhac; Gandhi Damaj; Philippe Gaulard; Laurence De Leval; François Lemonnier; Emmanuel Bachy; Sylvie Chevret; Olivier Hermine; Lucile Couronné; Arnaud Jaccard

ArticleOPEN ACCESS

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

HemaSphere

DOI: 10.1002/hem3.70081

0Citations

2Readers

Cite

CITATION STYLE

APA

Marouf, A., Chaubard, S., Liévin, R., Michot, J. M., Molinari, N., Rossignol, J., … Jaccard, A. (2025, January 1). Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA. HemaSphere. John Wiley and Sons Inc. https://doi.org/10.1002/hem3.70081

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

Cite

Register to see more suggestions